Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

11.09 -1.27 (-10.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2026 Add to My Watchlist

Price and Volume

Volume	5,794,801
Open	11.98
Bid (Size)	11.00 (600)
Ask (Size)	11.04 (1,400)
Prev. Close	12.36
Today's Range	10.94 - 12.20
52wk Range	5.900 - 28.25
Shares Outstanding	88,140,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗

January 27, 2026

The U.S. Food and Drug Administration lifted the clinical hold on a Phase 3 Trial, which was imposed on October 29, 2025 following the observation of Grade 4 liver transaminases and increased total...

Via Stocktwits

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗

January 16, 2026

Via Stocktwits

Performance

YTD	+20.4%	+20.4%
1 Month	+18.4%	+18.4%
3 Month	-18.3%	-18.3%
6 Month	-2.5%	-2.5%
1 Year	+15.3%	+15.3%

More News

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

Via Stocktwits

Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗

January 12, 2026

Via The Motley Fool

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗

December 29, 2025

Via The Motley Fool

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Via Investor's Business Daily

Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

Via FinancialNewsMedia

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

From MarketNewsUpdates.com

Via GlobeNewswire

2 Beaten-Down Stocks to Avoid Right Now ↗

November 15, 2025

Via The Motley Fool

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗

November 12, 2025

Via Benzinga

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗

November 11, 2025

Via Benzinga

What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗

November 11, 2025

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗

November 07, 2025

Via Investor's Business Daily

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗

November 07, 2025

Via The Motley Fool

Discover the top movers in Friday's pre-market session. ↗

November 07, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials ↗

November 06, 2025

Via Chartmill

What's going on in today's after hours session ↗

November 06, 2025

Via Chartmill

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

Via TokenRing AI

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130% ↗

November 02, 2025

Via The Motley Fool

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?

Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?

The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market

What is the current price of Intellia Therapeutics, Inc. - Common Stock?

The current price of Intellia Therapeutics, Inc. - Common Stock is 11.09

When was Intellia Therapeutics, Inc. - Common Stock last traded?

The last trade of Intellia Therapeutics, Inc. - Common Stock was at 02/05/26 04:00 PM ET

What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?

The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 977.48M

How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?

Intellia Therapeutics, Inc. - Common Stock has 977M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.